Perpignan

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia1 trial
• Metastatic breast cancer1 trial
• Myeloproliferative neoplasms1 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Active, not recruiting

  Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

  NCT06092879· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

  NCT05697146· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France

  NCT07839858· Novartis Pharmaceuticals· Source